Mankind Pharma Limited (the “Company”) is set to open its initial public offering of 40,058,844 Equity Shares (“Offer”) on Tuesday, April 25, 2023. The offer will close Thursday, April 27, 2023. The Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, that is, April 24, 2023.
The Price Band of the Offer has been fixed from ₹ 1,026 per Equity Share to ₹ 1,080 per Equity Share. Bids can be made for a minimum of 13 Equity Shares and in multiples of 13 Equity Shares thereafter.
The Offer of 40,058,844 Equity Shares comprises an offer for sale of 3,705,443 Equity Shares by Ramesh Juneja; 3,505,149 Equity Shares by Rajeev Juneja; 2,804,119 Equity Shares by Sheetal Arora (collectively, the “Promoter Selling Shareholders”); 17,405,559 Equity Shares by Cairnhill CIPEF Limited; 2,623,863 Equity Shares by Cairnhill CGPE Limited; 9,964,711 Equity Shares by Beige Limited; and 50,000 Equity Shares by Link Investment Trust (collectively, the “Investor Selling Shareholders”, and together with the “Promoter Selling Shareholders”, the “Selling Shareholders”).
